Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPhil Study Day Logo

This year’s 14th Annual Medical Sciences DPhil Day, a student-organised symposium, proudly showcased the varied and excellent biomedical and clinical research carried out by DPhil students across the Medical Sciences Division.

The event gave students the opportunity to present to their peers and see an exciting cross-section of ongoing research at Oxford’s many research sites.

3.JPG

Over 100 attendees attended 15 student talks covering a wide breadth of topics including neuroscience, organ transplantation, structural biology and vaccine design. Prizes were awarded to Malte Kaller (1st) and Janine Grey (2nd) for their outstanding presentations on myelination and drug development and active audience involvement was recognised with a prize for the best audience question awarded to Lancelot Millar. Students were also given the opportunity to present their posters with prizes awarded to Layal Liverpool (1st) and Amy Flaxman (2nd) for their work on host-viral interactions and microbiomes, respectively.

5.JPG

In addition to student presentations, Naomi Gibson, MSD Public Engagement Coordinator, spoke to students on the topic of Public Engagement, its increasing importance and how students can become involved as an integral part of their research careers.

The keynote lecture was provided by Professor Eleanor Riley of The London School of Hygiene and Tropical Medicine. Soon to take up a new post as Director of the Roslin Institute at Edinburgh University, we would like to thank Professor Riley for taking time travel to Oxford and share her insights from a long and inspiring career in multidisciplinary infectious disease research and malaria immunology.

2.JPG

The organising committee would also like to extend their thanks to Jane Rudman, Professor Afsie Sabokbar, Veliborka Milivojevic, our sponsors*, and to all the students who attended and presented their research for making the event a great success.

If you are interested in joining the organising committee for the 2018 event, please contact us or Jane Rudman for more information.

DPhil Day 2017 Committee

Agata Antepowicz, Alice Stelfox, Kento Kawai, Francesca Donnellan and Norbert Volkmar

 

Our sponsors

*Gilson, MACS Miltenyi Biotec, PeproTech, Sarstedt, Triplered

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.